ADAM9 and hepatocellular carcinoma: Previous studies have demonstrated the relationship between ADAM9 expression and clinicopathological features, including disease prognosis, shortens overall survival, tumor grade, metastasis, and the development of resistance in various cancers, including HCC [20].